Company Profile

Company NameJapan Hemotech Co., Ltd.
CEOHasegawa Hyo
Date of EstablishmentAugust 2019
Capital593,502,873yen
(Including capital reserve)
BankMizuho Bank
Shonan Shinkin Bank
IndustryE-2741 Medical equipment manufacturing industry
First class medical equipment manufacturing sales business permission(Permission number:14B1X10038)
Medical device manufacturing industry registration (registration number:13BZ201856)

Corporate philosophy

By providing blood adsorbers that remove unnecessary harmful substances from the blood, our company aims to work towards a society where anyone can receive safe, affordable apheresis treatment anywhere and at any time.

Management message

In the treatment of rare diseases where conventional medications and therapies alone do not yield sufficient effects, apheresis therapy is an expected new treatment approach.


Pharmaceuticals work by an “addition” approach, administering drugs to the body to achieve the desired therapeutic effect. In contrast, apheresis treatment takes a “subtraction” approach by removing unwanted or unnecessary substances from the patient’s blood extracorporeally (outside the body), and then returning the purified blood back into the body. This unique method of treatment can be considered a “cure for subtraction” as it involves removing harmful elements from the bloodstream to improve the patient’s condition.


However, apheresis therapy is not yet widely recognized, so active efforts are needed from doctors and patients to promote awareness, adoption, and technical support.


We aim to fulfill the hopes of many patients through apheresis therapy. We strive to promote the widespread adoption of this treatment method and expand access to opportunities for apheresis therapy, with the ultimate goal of creating a society where anyone, anytime, and anywhere can receive safe and affordable apheresis treatment.

The name of Japan HemoTech Corporation is derived from the abbreviation of “Japan Hemo Technology.” The company name reflects our desire to be a company that continues to contribute to apheresis medicine globally by disseminating blood purification technology from Japan to the world.

Board of Directors

CEO Hasegawa Hyo
Executive vice-presidentAkasu Hiroyuki
DirectorGe Kan
AuditorKawashima Norimichi

Company History

August 2019Establishment of Japan Hemotech Co., Ltd.
CEO Hasegawa Hyo
January 2020Opening of Yokohama Sales office
Yokohama TH Building 813, 1-2 Chitose-cho, Naka-ku, Yokohama-shi, Kanagawa
February 2020Capital increase: New capital 10,415,000 yen
March 2020Relocation of Main office 
NANOBIC2007 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki-shi, Kanagawa
December 2020Capital increase: New capital 87,005,390 yen
September 2021Establishment of Yokohama Research Institute
Yokohama Bio Industry Center 126, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama-shi, Kanagawa
August 2022Relocation of Yokohama Sales office
Yokohama TH Building 811, 1-2 Chitose-cho, Naka-ku, Yokohama-shi, Kanagawa
October 2022Opening of Tokyo Factory
2-30-10 Hyoe, Hachioji-shi, Tokyo
December 2022Capital increase: New capital 563,502,873 yen
July 2023Capital/capital reserves 293,502,873 yen 
December 2023Closure of Yokohama Sales Office
December 2023Opening of Kawasaki Sales office
KBIC117 7-7Sin-Kawasaki,Saiwai-ku,Kawasaki-shi,Kanagawa
February 2024Obtained Certification for Manufacturing and Sales of Class I Medical Devices
March 2024Registered as a Kawasaki SDGs Partner business
June 2024Registered Medical Device Manufacturer at Tokyo Factory
July 2024Capital/capital reserves 593,502,873 yen

Company Locations

Main office

〒212-0032
NANOBIC2007 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki-shi, Kanagawa
Phone: 044-223-8980

Access to Main office

By train

・JR Yokosuka Line ➔

alight at Shin-Kawasaki Station,
10 minutes on foot

・JR Nambu Line ➔

alight at Kashimada Station,
15 minutes on foot

Yokohama Research Institute

〒230-0045
Yokohama Bio Industry Center 126, 1-6 Suehiro-cho, Tsurumi-ku, Yokohama-shi, Kanagawa
Phone: 045-642-3831

Access to Yokohama Research Institute

By train

・JR Tsurumi Line ➔

alight at Tsurumi-Ono Station,
15 minutes on foot

By Bus (Duration: 12-15 minutes)

1) JR Keihin-Tohoku Line ➔



 Keikyu Line ➔

alight at Tsurumi Station,

exit via East Exit for bus terminal

alight at Keikyu Tsurumi Station,

exit via West Exit for bus terminal

2) Kawasaki Tsurumi-Rinko bus terminal: Tsuru 08 Line from Gate 8  (Bound for Fureyu)

➔ alight at RIKEN City University Graduate School Stataion,

3 minutes on foot

Tokyo Factory

〒192-0918

2-30-10 Hyoe, Hachioji-shi, Tokyo
Phone: 042-683-1520

Access to Tokyo Factory

By train

・JR Yokohama Line ➔

alight at Hachioji Minamino Station,
15 minutes on foot

Kawasaki Sales Office

〒231-0035

KBIC117 7-7 Sin-Kawasaki, Saiwai-ku, Kawasaki-shi,

Kanagawa
Phone: 044-589-7390

Access to Kawasaki Sales office

By train

・JR Yokosuka Line ➔

alight at Shin-Kawasaki Station,

10 minutes on foot

・JR Nambu Line ➔

alight at Kashimada Station,
15 minutes on foot